It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...
Australian researchers said that supervised diets with intermittent fasting were for children with serious health conditions, ...
Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish drugmaker's experimental ...
Unfortunately, too many insurers — including Medicare — still see obesity as a cosmetic issue instead of the disease that it ...
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
Obesity is a disease characterized by having excessive body fat, increasing a person’s risk for many serious health problems, ...
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
In this morning’s readout from Novo's phase 2 trial of monlunabant in 243 people with obesity and metabolic syndrome, it ...
Evidence shows that blockbuster weight-loss medications can reduce obesity even in children aged 6–11, but their long-term ...
The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...
Severe obesity is already a significant problem for many children, especially since obese children often become obese adults. Could the now popular weight-loss injection drugs be a solution for those ...